| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/14/2002 | WO2002020572A2 Nucleotide sequences coding for the chrs gene |
| 03/14/2002 | WO2002020570A2 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening |
| 03/14/2002 | WO2002020569A2 Mammalian genes; related reagents and methods |
| 03/14/2002 | WO2002020568A2 Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins |
| 03/14/2002 | WO2002020567A2 Mammalian cystatin-8 and its use to inhibit cancer procoagulant protein |
| 03/14/2002 | WO2002020565A2 Collections of repeat proteins comprising repeat modules |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020561A1 Novel polypeptides and anti-hiv drugs containing the same |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020559A1 Method for purifying recombinant proteins expressed as insoluble aggregates |
| 03/14/2002 | WO2002020558A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 03/14/2002 | WO2002020557A1 Extended native chemical ligation |
| 03/14/2002 | WO2002020556A2 Haplotypes of the gpr68 gene |
| 03/14/2002 | WO2002020555A2 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 03/14/2002 | WO2002020554A2 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 03/14/2002 | WO2002020548A1 Monocot seeds with increased lignan content |
| 03/14/2002 | WO2002020544A1 Process for preparing peptide derivatized oligomeric compounds |
| 03/14/2002 | WO2002020542A2 Nucleotide sequences which code for the gap2 gene |
| 03/14/2002 | WO2002020092A1 Use of serum response factor (srf) modulator for treating srf related diseases |
| 03/14/2002 | WO2002020060A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/14/2002 | WO2002020055A1 Remedies for heart failure |
| 03/14/2002 | WO2002020054A2 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy |
| 03/14/2002 | WO2002020053A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020052A1 Use of lipopeptides for immunotherapy of hiv-positive subjects |
| 03/14/2002 | WO2002020051A2 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments |
| 03/14/2002 | WO2002020050A2 Eiav p26 deletion vaccine and diagnostic |
| 03/14/2002 | WO2002020049A2 Eiav chimeric vaccine and diagnostic |
| 03/14/2002 | WO2002020048A1 A classical swine fever virus epitope vaccine and its producing method |
| 03/14/2002 | WO2002020047A2 Chlamydial peptides and their mimics in demyelinating disease |
| 03/14/2002 | WO2002020046A1 Multicomponent mscramm vaccine |
| 03/14/2002 | WO2002020041A2 Eia vaccine and diagnostic |
| 03/14/2002 | WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/14/2002 | WO2002020036A1 Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter |
| 03/14/2002 | WO2002020035A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020034A1 'pseudo'-native chemical ligation |
| 03/14/2002 | WO2002020033A1 Polymer-modified synthetic proteins |
| 03/14/2002 | WO2002020032A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/14/2002 | WO2002019986A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | WO2002019968A2 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
| 03/14/2002 | WO2002019965A2 Heat shock response and virus replication |
| 03/14/2002 | WO2002019963A2 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | WO2002019814A2 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety |
| 03/14/2002 | WO2002019813A2 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery |
| 03/14/2002 | WO2002019812A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 03/14/2002 | WO2002019803A1 Disease-resistant plants and method of constructing the same |
| 03/14/2002 | WO2001096564A3 Hla-g (hla-g7) isoform and its applications |
| 03/14/2002 | WO2001094539A3 A human kaza1 inhibitory factor 11 and polynucleotide encoding it |
| 03/14/2002 | WO2001094534A3 A novel polypeptide, a human transcription factor 9.57 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001094531A3 A novel polypeptide, a human uterine globulin 12 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001090189A3 G-protein coupled receptor org3. |
| 03/14/2002 | WO2001087921A3 Gene responsible for stargardt-like dominant macular dystrophy |
| 03/14/2002 | WO2001085756A3 Site-selective acyl transfer |
| 03/14/2002 | WO2001083682A3 A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 03/14/2002 | WO2001081535A3 A novel polypeptide, a human pax protein 9.9 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001079428A3 A novel polypeptide, a human dna mismatch repair gene protein 8.9 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001079278A8 Lactobacillus johnsonii bacteriocin, active against helicobacter pylori |
| 03/14/2002 | WO2001078655A3 Methods and compositions for heat shock protein mediated immunotherapy of melanoma |
| 03/14/2002 | WO2001077320A3 Regulation of human hm74-like g protein coupled receptor |
| 03/14/2002 | WO2001077293A3 Gp40 and uses thereof |
| 03/14/2002 | WO2001077147A3 New bromodomain protein |
| 03/14/2002 | WO2001075059A3 A novel polypeptide, human gtp-regulatory protein 11 and a polynucleotide encoding the same |
| 03/14/2002 | WO2001075048A3 A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide |
| 03/14/2002 | WO2001070986A3 Helical protein zalpha51 |
| 03/14/2002 | WO2001070944A3 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene. |
| 03/14/2002 | WO2001070929A3 Transgenic plants containing heat shock protein |
| 03/14/2002 | WO2001070805A3 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them |
| 03/14/2002 | WO2001070768A3 Receptor-binding compounds and method for identifying them |
| 03/14/2002 | WO2001070173A3 Immunokine composition and method |
| 03/14/2002 | WO2001068882A3 Methods for homologous recombination |
| 03/14/2002 | WO2001068881A3 Dna sequence and a method for the in vivo marking and the analysis of dna/chromatin in cells |
| 03/14/2002 | WO2001066749A3 A member of the lectin superfamily |
| 03/14/2002 | WO2001066696A3 Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
| 03/14/2002 | WO2001066138A3 Dna vaccines against poxviruses |
| 03/14/2002 | WO2001064920A3 Hybrid expression of neisserial proteins |
| 03/14/2002 | WO2001063278A3 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 03/14/2002 | WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof |
| 03/14/2002 | WO2001062774A3 Purified lh |
| 03/14/2002 | WO2001061046A3 HUMAN VNO cDNA LIBRARIES |
| 03/14/2002 | WO2001061011A3 Human thrombospondin repeat proteins and polynucleotides encoding the same |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001061001A3 Novel, central nervous protein, that modulates k+ flows |
| 03/14/2002 | WO2001060974A3 Method for an extraction of proteins from a single cell |
| 03/14/2002 | WO2001059064A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001058921A9 Methods and compositions for generating angiostatin |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001057080A3 Neuropeptide-like polypeptide zpep17 |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055312A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001055198A3 Dermo- and gastro-specific sphingolipid activator |
| 03/14/2002 | WO2001055179A3 Nucleic acids encoding polypeptides with homology to olfactory receptors |
| 03/14/2002 | WO2001051519A3 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 03/14/2002 | WO2001051512A3 Human and parasite orphan receptor proteins |
| 03/14/2002 | WO2001049728A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 03/14/2002 | WO2001047551A3 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 03/14/2002 | WO2001046412A3 Interaction proteins for the stat transcription factor |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | WO2001042290A3 Novel steroid-activated nuclear receptors and uses therefor |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |